Gemcitabine plus S-1 for metastatic pancreatic cancer
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000012836
Abstract: Abstract To investigate the treatment effects of gemcitabine plus S-1 (GS) for metastatic pancreatic cancer in our institution. Data from 41 patients with metastatic pancreatic cancer treated with GS regimen in West China Hospital, Sichuan… read more here.
Keywords: plus metastatic; metastatic pancreatic; gemcitabine plus; pancreatic cancer ... See more keywords